These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 178342)
1. Relation between the inhibition of aggregation and the concentration of cAMP in human and rat platelets. Michel H; Caen JP; Born GV; Miller R; D'Auriac GA; Meyer P Br J Haematol; 1976 May; 33(1):27-38. PubMed ID: 178342 [TBL] [Abstract][Full Text] [Related]
2. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets. Mills DC; Smith JB Biochem J; 1971 Jan; 121(2):185-96. PubMed ID: 4330088 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Haslam RJ; Davidson MM; Desjardins JV Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change. Steen VM; Holmsen H Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615 [TBL] [Abstract][Full Text] [Related]
6. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Maurice DH; Haslam RJ Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060 [TBL] [Abstract][Full Text] [Related]
7. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation. Zahavi M; Zahavi J; Kakkar VV Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233. Dawicki DD; Agarwal KC; Parks RE Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942 [TBL] [Abstract][Full Text] [Related]
9. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets. Lam SC; Guccione MA; Packham MA; Mustard JF Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543 [TBL] [Abstract][Full Text] [Related]
10. Role of plasma adenosine in the antiplatelet action of HL 725, a potent inhibitor of cAMP phosphodiesterase: species differences. Agarwal KC; Buckley RS; Parks RE Thromb Res; 1987 Jul; 47(2):191-200. PubMed ID: 2821650 [TBL] [Abstract][Full Text] [Related]
11. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat. Ashida SI; Abiko Y Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522 [TBL] [Abstract][Full Text] [Related]
12. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function. Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373 [TBL] [Abstract][Full Text] [Related]
13. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets. Salzman EW Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670 [TBL] [Abstract][Full Text] [Related]
14. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets. Zahavi M; Zahavi J; Kakkar VV Life Sci; 1984 Oct; 35(14):1497-503. PubMed ID: 6090838 [TBL] [Abstract][Full Text] [Related]
15. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2. Miller OV; Gorman RR J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467 [TBL] [Abstract][Full Text] [Related]
16. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets. Williams KA; Murphy W; Haslam RJ Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206 [TBL] [Abstract][Full Text] [Related]
17. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate. Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055 [TBL] [Abstract][Full Text] [Related]
18. Potentiation of antiaggregating activity of adenosine by a phosphodiesterase inhibitor, EG626 (oxagrelate), in human platelets in vitro. Azuma H; Takashima Y; Ishikawa M; Yamakado T Jpn J Pharmacol; 1984 Feb; 34(2):159-70. PubMed ID: 6205194 [TBL] [Abstract][Full Text] [Related]
19. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation. Haslam RJ; Rosson GM Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501 [No Abstract] [Full Text] [Related]
20. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood. Kikura M; Kazama T; Ikeda T; Sato S Platelets; 2000 Dec; 11(8):446-58. PubMed ID: 11177444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]